Status:
UNKNOWN
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey
Lead Sponsor:
SCARE (Study group for carbapenem resistance)
Collaborating Sponsors:
European Society of Intensive Care Medicine
Conditions:
Bacteremia
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
In this observational study, it is aimed to investigate the mortality and morbidity rates of hospital-acquired blood stream infections that are treated in intensive care units (ICU). The effects of pr...
Detailed Description
Blood stream infection (BSI) is defined as the identification of a culprit pathogen in the blood culture sample of a participant. As such, and once contaminants are excluded, BSI is the only cause of ...
Eligibility Criteria
Inclusion
- Age \> 18 Years.
- Hospital Acquired Bloodstream Infection (HA-BSI).
- Treated in the ICU.
- ICU acquired OR Hospital acquired prior to ICU admission
Exclusion
- Patients that had a positive blood culture in the hospital and transferred to ICU for a different reason than specific treatment of the causes or consequences of HA-BSI.
- Previous inclusion in the study.
- HA-BSI is defined as a positive blood culture (BC) sampled after 48 hours following hospital admission.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
810 Patients enrolled
Trial Details
Trial ID
NCT04304456
Start Date
June 1 2020
End Date
April 1 2022
Last Update
March 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.